Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia

Journal of Pharmacology and Experimental Therapeutics(2024)10.1016/j.jpet.2024.100532Source: DataRank Database

Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 2.04)OA: greenTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Christopher Stone ORCID,Mark Broadwin ORCID,Meghamsh Kanuparthy ORCID,Sharif A. Sabe ORCID,Ju-Woo Nho ORCID

Live enrichment

PubMed:40023609 PMC:PMC13095462 OpenAlex:https://openalex.org/W4405756803

Rhode Island Foundation

Grant: 1472420231352

Rhode Island Foundation

Grant: R01HL46716

Rhode Island Foundation

Grant: R01HL128831

National Institutes of Health

Grant: T32HL160517

National Heart, Lung, and Blood Institute

Grant: 1F32HL160063-01

National Heart, Lung, and Blood Institute

Grant: R56HL133624-05

NIGMS NIH HHS

Grant: P20 GM103652

NHLBI NIH HHS

Grant: F32 HL160063

NHLBI NIH HHS

Grant: R01 HL133624

NHLBI NIH HHS

Grant: R01 HL046716

FWCI

2.04

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13095462/pdf/main.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022356524421812?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022356524421812?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13095462/

Fields of Study

Diabetes Treatment and ManagementPeptidase Inhibition and AnalysisPancreatic function and diabetesAnimalsLinagliptinDipeptidyl-Peptidase IV InhibitorsApoptosisFibrosisMyocardial IschemiaDisease Models, AnimalSwineChronic DiseaseMale

MeSH Terms

LinagliptinAnimalsChronic DiseaseDisease Models, AnimalFemaleFibrosisMaleSwineMyocardial IschemiaApoptosisDipeptidyl-Peptidase IV Inhibitors

Keywords

LinagliptinDipeptidyl peptidase-4MedicineFibrosisIschemiaPharmacologyMyocardial ischemiaApoptosisCardiologyCardiac function curveInternal medicineDiabetes mellitusEndocrinologyChemistryType 2 diabetesHeart failureBiochemistryChronic Myocardial IschemiaDipeptidyl Peptidase 4 Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being